Your partner for dermatological trials — trusted, proven, and precise
Sponsors rely on Biorasi’s experience across common and rare skin conditions — backed by responsive teams, integrated platforms, and real-world delivery.
WHY BIORASI FOR DERMATOLOGY?
From pediatric plaque psoriasis to adult rosacea and microbiome therapies, Biorasi brings discipline to every dermatology protocol. Our role is not just execution — safeguarding trial integrity and meeting sponsor timelines while fostering trust across investigators, sites, and regulators.
Subspecialties
- Rosacea
- Atopic Dermatitis
- Plaque Psoriasis
- Pediatric Dermatology
- Rare Skin Disorders
- Skin Microbiome-Based Therapies
Proof of
Performance
- 25 Studies
- 16 Indications
- 6,510 Patients Enrolled
Case Studies and Results
- Rapid & Time-Sensitive Execution in Rosacea
- Enrolled 140 patients at 8 sites in 4 months
- Achieved a 4% dropout rate (vs. expected 19%)
- Topline results delivered 7 days ahead of schedule
- Demonstrated controlled execution in a crowded market
FROM OUR PARTNERS
“From the standpoint of being able to recruit, educate, and convince sites this is something they should take on and they can deploy, Biorasi did a tremendous job working with sites to educate them and get them on board to start what is essentially a brand-new sort of class of therapeutic which is a live topical spray.”
